Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;21(3):73-89.
doi: 10.2174/0115701638243222230920051050.

In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets

V Alagarsamy  1 , V Raja Solomon  1 , S Murugesan  2 , P Shyam Sundar  1 , M D Muzaffar-Ur-Rehman  3 , A Chandu  2 , A Dharshini Aishwarya  1 , B Narendhar  1 , M T Sulthana  1 , V Ravikumar  4
Affiliations

In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets

V Alagarsamy et al. Curr Drug Discov Technol. 2024.

Abstract

Background: There are very few small-molecule drug candidates developed against SARS-CoV-2 that have been revealed since the epidemic began in November 2019. The typical medicinal chemistry discovery approach requires more than a decade of the year of painstaking research and development and a significant financial guarantee, which is not feasible in the challenge of the current epidemic.

Objective: This current study proposes to find and identify the most effective and promising phytomolecules against SARS-CoV-2 in six essential proteins (3CL protease, Main protease, Papain- Like protease, N-protein RNA binding domain, RNA-dependent RNA polymerase, and Spike receptor binding domain target through in silico screening of 63 phytomolecules from six different Ayurveda medicinal plants.

Methods: The phytomolecules and SARS-CoV-2 proteins were taken from public domain databases such as PubChem and RCSB Protein Data Bank. For in silico screening, the molecular interactions, binding energy, and ADMET properties were investigated.

Results: The structure-based molecular docking reveals some molecules' greater affinity towards the target than the co-crystal ligand. Our results show that tannic acid, cyanidin-3-rutinoside, zeaxanthin, and carbolactone are phytomolecules capable of inhibiting SARS-CoV-2 target proteins in the least energy conformations. Tannic acid had the least binding energy of -8.8 kcal/mol, which is better than the binding energy of its corresponding co-crystal ligand (-7.5 kcal/mol) against 3 CL protease. Also, it has shown the least binding energy of -9.9 kcal/mol with a more significant number of conventional hydrogen bond interactions against the RdRp target. Cyanidin-3-rutinoside showed binding energy values of -8.8 and -7.6 kcal/mol against Main protease and Papain-like protease, respectively. Zeaxanthin was the top candidate in the N protein RBD with a binding score of - 8.4 kcal/mol, which is slightly better when compared to a co-crystal ligand (-8.2 kcal/mol). In the spike, carbolactone was the suitable candidate with the binding energy of -7.2 kcal/mol and formed a conventional hydrogen bond and two hydrophobic interactions. The best binding affinity-scored phytomolecules were selected for the MD simulations studies.

Conclusion: The present in silico screening study suggested that active phytomolecules from medicinal plants could inhibit SARS-CoV-2 targets. The elite docked compounds with drug-like properties have a harmless ADMET profile, which may help to develop promising COVID-19 inhibitors.

Keywords: ADMET.; COVID-19; MD simulation; SARS-CoV-2; medicinal plants; molecular docking.

PubMed Disclaimer

References

    1. Anand K.; Ziebuhr J.; Wadhwani P.; Mesters J.R.; Hilgenfeld R.; Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science 2003,300(5626),1763-1767 - DOI - PubMed
    1. Anderson R.M.; Heesterbeek H.; Klinkenberg D.; Hollingsworth T.D.; Hollingsworth, How will country-based mitigation measures influence the course of the COVID-19 epidemic? The Lancet 2020,395(10228),931-934
    1. Cinatl J.; Morgenstern B.; Bauer G.; Chandra P.; Rabenau H.; Doerr H.W.; Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003,361(9374),2045-2046 - DOI - PubMed
    1. Gates B.; Responding to Covid-19 — A once-in-a-century pandemic? N Engl J Med 2020,382(18),1677-1679
    1. Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R/. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J Biomol Struct Dyn 2020,39(7),2617-2627 - DOI

MeSH terms